-Newsclick.in About 200 families residing in the informal housing settlements in Delhi were directly or indirectly affected by the demolition drive carried out by the authorities in the month of April. Slum dwellers in the national capital find their woes compounded by the looming threat of forced evictions by the government authorities – that continued apace last year and has not spared families despite the resurgence in COVID-19 cases now. About 200 families...

-The Hindu The U.S.-supported move will have an effect if countries simultaneously address non-IP bottlenecks among other things The United States has finally relented and declared its support for a temporary waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement for COVID-19 vaccines at the World Trade Organisation (WTO). In October 2020, India and South Africa, at the WTO, proposed waiving Sections 1, 4, 5, and 7 of Part II...

-The Hindu Three complaints filed with human Rights commission against police Bengaluru: Police across the State on Monday began enforcing a strict lockdown, often resorting to caning motorists and people on the streets. Such instances were reported from across the State. In many instances, the policemen allegedly caned everyone in sight indiscriminately, even those out on medical emergencies and other permitted activities, raising hackles. At least three complaints — by two lawyers and...

-Financial Express If patents continue to determine global access to vaccines and drugs, then fighting Covid-19 will remain a distant dream for most countries Vaccines are badly required by the world, as are drugs like Remdesivir and Tocilizumab, and medical equipment like ventilators and oxygen concentrators. A large number of countries, particularly low- and middle-income ones, are struggling to access vaccines, drugs and equipment. There cannot be a more important occasion than the...

-The Hindu Business Line It’s only an open-ended deal with co-developer Bharat Biotech, says top source The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended. Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology...